TEVOGEN BIO HOLDINGS INC.

Press Releases Tevogen Bio Holdings Inc.

Equities

TVGN

US88165K1016

Real-time Estimate Cboe BZX Other stock markets 07:16:37 20/05/2024 pm IST			5-day change	1st Jan Change
0.81 ^USD	-1.22%		-18.90%	-92.71%

13/05	Investors Eye Key Inflation Data in Days Ahead as US Futures Trend Modestly Higher Monday	MT
13/05	Top Premarket Gainers	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Tevogen Bio Appoints Former Police Chief & FBI National Academy Graduate, William Keane, as Vice President of Strategic Initiatives	16/05	GL
Tevogen Bio Announces Up to $50 Million in Financing to Further Advance Operational Objectives	11/05	GL
Tevogen Bio Announces Full Year 2023 Financial Results and Upcoming Operational Objectives	01/05	GL
Tevogen Bio CEO Highlights Expected Reporting of a $94.9 Million Liability Elimination, AI Initiative, and Leadership Appointments	26/04	GL
Tevogen Bio’s Chief Scientific Officer Speaks on the Harnessing of Cytotoxic T Lymphocytes (CTLs) to Target Cancers	11/04	GL
Tevogen Bio Appoints Tapan V Shah as Head of Investor Relations and Corporate Development	03/04	GL
Tevogen Bio Reports Series A-1 Preferred Stock Investment at $10 Conversion Price	28/03	GL
Tevogen Bio Reports Its Investigational SARS-CoV-2 Specific T Cell Therapy, TVGN-489, Retains Activity Against the Dominant JN.1 Variant	20/03	BU
Tevogen Bio Holdings Congratulates its Board Member and Esteemed Global Safety Management Expert, Victor Sordillo, on His appointment as Managing Director of Risk Advisory Services at Verita	05/03	BU
Mittul Mehta, Head of Tevogen's Artificial Intelligence Initiative Tevogen.ai, Emphasizes Importance of Proactive Talent Development for Biopharmaceutical Sector to Allow Rapid Adoption of AI	28/02	BU
Cell Therapy Company Tevogen Bio Holdings Inc. Prepares to Launch Crucial Genetic Predisposition Study in Preparation to Investigate the Potential of TVGN 489 to Address Critical Unmet Need for Long COVID Treatment	21/02	BU
Cell Therapy Company Tevogen Bio Holdings Inc. (Nasdaq: TVGN) Rings Opening Bell at Nasdaq Exchange on February 15th, 2024, Begins Public Trading on the Open Market	17/02	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.

BENEFIT NOW